Clinical Trial Update: Safety and Performance of Agilik in CP [NA]

View source ↗

Summary

A clinical trial evaluating the safety and performance of Agilik in cerebral palsy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• Agilik

Snippet

Sponsor: IRCCS Eugenio Medea | Conditions: Cerebral Palsy | NA | Status: TERMINATED